Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer

    England. National Institute for Health and Care Excellence.
    This evaluation uses new cost-effectiveness estimates to update olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (NICE technology appraisal guidance TA831). No new clinical evidence was reviewed. Treatments for BRCA mutation-positive hormone-relapsed meta...
    Neoplasias de la Próstata/tratamiento farmacológico, Mutación/efectos de los fármacos, Proteína BRCA1, Antineoplásicos Hormonales/uso terapéutico
    Texto completo

    European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

    Fassnacht, M; Dekkers, OM; Else, T; Baudin, E; Berruti, A; de Krijger, R; Haak, HR; Mihai, R; Assie, G; Terzolo, M.
    Eur. j. endocrinol; 179 (4), 2018
    Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of patients with ACC based on the GRADE (Grading of Recomm...
    Neoplasias de la Corteza Suprarrenal, Metástasis de la Neoplasia, Antineoplásicos Hormonales/uso terapéutico, Etopósido/administración & dosificación, Mitotano/uso terapéutico, Doxorrubicina/uso terapéutico, Carcinoma Corticosuprarrenal/diagnóstico, Carcinoma Corticosuprarrenal, Carcinoma Corticosuprarrenal/tratamiento farmacológico, Radioterapia, Cisplatino/uso terapéutico, Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico, Ablación por Catéter, Adrenalectomía, Neoplasias de la Corteza Suprarrenal/terapia, Carcinoma Corticosuprarrenal/terapia, Quimioembolización Terapéutica
    Texto completo